UNITED STATES | |||||||||||||||||
SECURITIES AND EXCHANGE COMMISSION | |||||||||||||||||
Washington, D.C. 20549 | |||||||||||||||||
SCHEDULE 14A | |||||||||||||||||
Proxy Statement Pursuant to Section 14(a) of the | |||||||||||||||||
Securities Exchange Act of 1934 | |||||||||||||||||
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ | |||||||||||||||||
Check the appropriate box: | |||||||||||||||||
☐ | Preliminary Proxy Statement | ||||||||||||||||
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||||||||||||||
☐ | Definitive Proxy Statement | ||||||||||||||||
☒ | Definitive Additional Materials | ||||||||||||||||
☐ | Soliciting Material under §240.14a-12 | ||||||||||||||||
LIANBIO | |||||||||||||||||
(Name of Registrant as Specified in Its Charter) | |||||||||||||||||
(Name of Person(s) Filing Proxy Statement if other than Registrant) | |||||||||||||||||
Payment of Filing Fee (Check the appropriate box): | |||||||||||||||||
☒ | No fee required. | ||||||||||||||||
☐ | Fee paid previously with preliminary materials. | ||||||||||||||||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 | ||||||||||||||||